Evolving hypotheses on the mechanisms underlying ACS
Peter Libby considers how the pathophysiology of atherosclerosis and the mechanisms of ACS are changing, as a result of preventive therapies and a change in risk factors, toward superficial erosion.
Educational information
Vascular Biology Working Group Meeting at ACC 2016, Chicago, IL, USA
Disclosures
Peter Libby, MD - Mallinckrodt Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: